A Mammoth Becomes A Unicorn: Inside a Scientist-Founder’s Journey from Pre-Seed to Series D (NFX Bio)


Manage episode 301898441 series 2528675
Player FM과 저희 커뮤니티의 The NFX Podcast 콘텐츠는 모두 원 저작자에게 속하며 Player FM이 아닌 작가가 저작권을 갖습니다. 오디오는 해당 서버에서 직접 스트리밍 됩니다. 구독 버튼을 눌러 Player FM에서 업데이트 현황을 확인하세요. 혹은 다른 팟캐스트 앱에서 URL을 불러오세요.
Today, Mammoth Biosciences announced their series C and D at more than a $1B valuation. Mammoth is a startup story that Founders should be following because there is so much to learn from their path from the lab to unicorn status. At no other time in modern history has the need for science to lead our society toward a better future been more apparent and immense. We can meet this need by investing in the next generation of tech-bio companies like Mammoth. NFX led Mammoth’s Pre-Seed and Seed rounds, co-led the Series A, and has invested in every round including today’s Series D. We even helped them name the company. Mammoth is the poster child for the NFX strategy of using network effects to build bio platforms — this approach to building tech-bio businesses should allow them to get 10x the size of a normal bio company. It’s also a great example of how NFX Bio supports Scientist-Founders as they become great Founders and CEOs after they leave the lab. Listen in with Omri Drory, head of NFX Bio, and Partner James Currier as they take an inside look with Mammoth’s Co-Founder & CEO Trevor Martin at his journey from idea to unicorn — for the benefit of up-and-coming Scientist-Founders worldwide.

140 에피소드